D. Fletcher

662 total citations
17 papers, 555 citations indexed

About

D. Fletcher is a scholar working on Immunology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, D. Fletcher has authored 17 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Organic Chemistry and 4 papers in Molecular Biology. Recurrent topics in D. Fletcher's work include Synthesis of β-Lactam Compounds (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Inflammatory mediators and NSAID effects (3 papers). D. Fletcher is often cited by papers focused on Synthesis of β-Lactam Compounds (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Inflammatory mediators and NSAID effects (3 papers). D. Fletcher collaborates with scholars based in United States and Netherlands. D. Fletcher's co-authors include Silvi Luell, Alan L. Maycock, Bonnie M. Ashe, Pam S. Dellea, Anna Christen, Philip R. Davies, Denise M. Visco, William R. Widmer, Tsau-Yen Lin and James D. Bergstrom and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

D. Fletcher

17 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Fletcher United States 9 159 155 125 79 77 17 555
D. L. Widomski United States 17 194 1.2× 214 1.4× 160 1.3× 59 0.7× 69 0.9× 44 758
H. Heuer Germany 15 224 1.4× 103 0.7× 158 1.3× 60 0.8× 72 0.9× 43 725
K. Rühling Germany 10 151 0.9× 176 1.1× 134 1.1× 20 0.3× 38 0.5× 20 629
Mark T. Yates United States 13 204 1.3× 78 0.5× 116 0.9× 85 1.1× 25 0.3× 19 731
Egil Fosslien United States 10 216 1.4× 56 0.4× 45 0.4× 40 0.5× 59 0.8× 18 720
J. N. Sharma Malaysia 15 175 1.1× 87 0.6× 65 0.5× 37 0.5× 38 0.5× 50 665
Kathrin Heermeier Germany 14 386 2.4× 269 1.7× 147 1.2× 25 0.3× 43 0.6× 18 891
Thomas D. Oglesby United States 12 167 1.1× 80 0.5× 116 0.9× 39 0.5× 26 0.3× 14 470
M. Goerig Germany 13 247 1.6× 68 0.4× 85 0.7× 24 0.3× 27 0.4× 28 678
H. A. Dresel Germany 16 236 1.5× 177 1.1× 42 0.3× 73 0.9× 23 0.3× 28 794

Countries citing papers authored by D. Fletcher

Since Specialization
Citations

This map shows the geographic impact of D. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Fletcher more than expected).

Fields of papers citing papers by D. Fletcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Fletcher. The network helps show where D. Fletcher may publish in the future.

Co-authorship network of co-authors of D. Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of D. Fletcher. A scholar is included among the top collaborators of D. Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Fletcher. D. Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fletcher, D., et al.. (2001). Chemical chelation as a novel method of NMB reversal characterization of the org 25969 NMB complex. European Journal of Anaesthesiology. 18(Supplement 23). 99–99. 7 indexed citations
2.
Detmers, Patricia A., Melba Hernandez, John S. Mudgett, et al.. (2000). Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice. The Journal of Immunology. 165(6). 3430–3435. 177 indexed citations
3.
Fletcher, D., et al.. (1998). Therapeutic Administration of a Selective Inhibitor of Nitric Oxide Synthase Does Not Ameliorate the Chronic Inflammation and Tissue Damage Associated with Adjuvant-Induced Arthritis in Rats. Journal of Pharmacology and Experimental Therapeutics. 284(2). 714–721. 79 indexed citations
4.
Fletcher, D., Jayne Chin, Linda A. Egger, et al.. (1995). A Synthetic Inhibitor of Interleukin-lβ Converting Enzyme Prevents Endotoxin-Induced Interleukin-lβ Production In Vitro and In Vivo. Journal of Interferon & Cytokine Research. 15(3). 243–248. 35 indexed citations
5.
Shah, S. K., D. Fletcher, Bonnie M. Ashe, et al.. (1995). Orally Active .beta.-Lactam Inhibitors of Human Leukocyte Elastase. 3. Stereospecific Synthesis and Structure-Activity Relationships for 3,3-Dialkylazetidin-2-ones. Journal of Medicinal Chemistry. 38(13). 2449–2462. 74 indexed citations
6.
Fletcher, D., Robert J. Bonney, James B. Doherty, et al.. (1995). An inhibitor of leukocyte elastase prevents immune complex-mediated hemorrhage in the rat lung.. Journal of Pharmacology and Experimental Therapeutics. 274(1). 548–554. 7 indexed citations
8.
Thompson, Kevan R., Paul E. Finke, Shrenik K. Shah, et al.. (1993). Inhibition of human leukocyte elastase. 7. Inhibition by 6-substituted penicillin amides.. Bioorganic & Medicinal Chemistry Letters. 3(11). 2289–2294. 7 indexed citations
9.
Shah, Shrenik K., Conrad P. Dorn, Paul E. Finke, et al.. (1993). ChemInform Abstract: Orally Active β‐Lactam Inhibitors of Human Leukocyte Elastase‐1. Activity of 3,3‐Diethyl‐2‐azetidinones.. ChemInform. 24(20). 1 indexed citations
10.
Stolk, Jan, Arjan Rudolphus, Philip R. Davies, et al.. (1992). Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster. The Journal of Pathology. 167(3). 349–356. 60 indexed citations
11.
Davies, Philip R., Bonnie M. Ashe, Robert J. Bonney, et al.. (1991). The Discovery and Biologic Properties of Cephalosporin‐Based Inhibitors of PMN Elastase. Annals of the New York Academy of Sciences. 624(1). 219–229. 24 indexed citations
12.
Opas, Evan E., Pam S. Dellea, D. Fletcher, Philip R. Davies, & John L. Humes. (1991). The in Vitro and in Vivo Recovery of PMN Elastase:Beta‐Lactam Inhibitor Complexes by Cation Exchange Chromatography. Annals of the New York Academy of Sciences. 624(1). 348–349. 2 indexed citations
13.
Bonney, Robert J., Bonnie M. Ashe, Alan L. Maycock, et al.. (1989). Pharmacological profile of the substituted beta‐lactam L‐659,286: A member of a new class of human PMN elastase inhibitors. Journal of Cellular Biochemistry. 39(1). 47–53. 27 indexed citations
14.
Fletcher, D., et al.. (1989). Variability of peritoneal clearances for apolipoprotein and its relationship to susceptibility for atherosclerotic changes in CAPD.. PubMed. 5. 185–90. 3 indexed citations
15.
Fletcher, D., et al.. (1980). Activation of a complex of C1r and C1s subcomponents of human complement C1 by the third subcomponent C1q.. Journal of Biological Chemistry. 255(16). 7756–7762. 24 indexed citations
16.
Fletcher, D., H R Williams, & Tsau-Yen Lin. (1978). Effects of human polymorphonuclear leukocyte collagenase on sub-component C1q of the first component of human complement. Biochimica et Biophysica Acta (BBA) - General Subjects. 540(2). 270–277. 7 indexed citations
17.
Fletcher, D. & Tsau-Yen Lin. (1973). Incorporation of l-leucine and d-glucosamine into skin fibroblasts derived from cystic fibrosis and normal individuals. Clinica Chimica Acta. 44(1). 5–19. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026